Meeting Coverage:

Association for Research in Vision & Ophthalmology

ARVO: 2025

Treating DR with Axitinib

Show Description +

Dr. Shah explains the longitudinal quantitative ultra-widefield retinal leakage assessment after a single axitinib hydrogel injection (OTX-TKI, Ocular Therapeutix) from the HELIOS trial for diabetic retinopathy.

Posted: 5/16/2025

Treating DR with Axitinib

Dr. Shah explains the longitudinal quantitative ultra-widefield retinal leakage assessment after a single axitinib hydrogel injection (OTX-TKI, Ocular Therapeutix) from the HELIOS trial for diabetic retinopathy.

Posted: 5/16/2025


Please log in to leave a comment.

More From ARVO: 2025 Coverage